Objective In 2014, the European Society of Cardiology (ESC) recommended the use of a novel risk prediction model (HCM Risk-SCD) to guide use of implantable cardioverter defibrillators (ICD) for the primary prevention of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM). We sought to determine the performance of HCM Risk-SCD by conducting a systematic review and meta-analysis of articles reporting on the prevalence of SCD within 5 years of evaluation in low, intermediate and high-risk patients as defined by the 2014 guidelines (predicted risk <4%, 4%-<6% and ≥6%, respectively). Methods The protocol was registered with PROSPERO (registration number: CRD42017064203). MEDLINE and manual searches for papers publ...
We performed a systematic literature review of recommended 'major' and 'possible' clinical risk mark...
We performed a systematic literature review of recommended 'major' and 'possible' clinical risk mark...
Background: Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disease associated with high popu...
Objective In 2014, the European Society of Cardiology (ESC) recommended the use of a novel risk pred...
Objective: In 2014, the European Society of Cardiology (ESC) recommended the use of a novel risk pre...
none21noObjective: In 2014, the European Society of Cardiology (ESC) recommended the use of a novel ...
OBJECTIVE: In 2014, the European Society of Cardiology (ESC) recommended the use of a novel risk pre...
Abstract Background: The new European Society of Cardiology guidelines for hypertrophic cardiomyopa...
Aims: Hypertrophic cardiomyopathy(HCM)is a leading cause of sudden cardiac death (SCD) in young adul...
Aims: Hypertrophic cardiomyopathy(HCM)is a leading cause of sudden cardiac death (SCD) in young adul...
Aims: Hypertrophic cardiomyopathy(HCM)is a leading cause of sudden cardiac death (SCD) in young adul...
Hypertrophic cardiomyopathy is one of the main causes of sudden death in young people. Recent clinic...
Context Recently, the implantable cardioverter-defibrillator (ICD) has been promoted for prevention ...
Background: Sudden cardiac death (SCD) is the most devastating complication of hypertrophic cardiomy...
Sudden cardiac death (SCD) is the most devastating complication of hypertrophic cardiomyopathy (HCM)...
We performed a systematic literature review of recommended 'major' and 'possible' clinical risk mark...
We performed a systematic literature review of recommended 'major' and 'possible' clinical risk mark...
Background: Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disease associated with high popu...
Objective In 2014, the European Society of Cardiology (ESC) recommended the use of a novel risk pred...
Objective: In 2014, the European Society of Cardiology (ESC) recommended the use of a novel risk pre...
none21noObjective: In 2014, the European Society of Cardiology (ESC) recommended the use of a novel ...
OBJECTIVE: In 2014, the European Society of Cardiology (ESC) recommended the use of a novel risk pre...
Abstract Background: The new European Society of Cardiology guidelines for hypertrophic cardiomyopa...
Aims: Hypertrophic cardiomyopathy(HCM)is a leading cause of sudden cardiac death (SCD) in young adul...
Aims: Hypertrophic cardiomyopathy(HCM)is a leading cause of sudden cardiac death (SCD) in young adul...
Aims: Hypertrophic cardiomyopathy(HCM)is a leading cause of sudden cardiac death (SCD) in young adul...
Hypertrophic cardiomyopathy is one of the main causes of sudden death in young people. Recent clinic...
Context Recently, the implantable cardioverter-defibrillator (ICD) has been promoted for prevention ...
Background: Sudden cardiac death (SCD) is the most devastating complication of hypertrophic cardiomy...
Sudden cardiac death (SCD) is the most devastating complication of hypertrophic cardiomyopathy (HCM)...
We performed a systematic literature review of recommended 'major' and 'possible' clinical risk mark...
We performed a systematic literature review of recommended 'major' and 'possible' clinical risk mark...
Background: Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disease associated with high popu...